ALKERMES | ALKS - Należności Handlowe





Należności Handlowe Zmiana Data
AbbVie USD 13.82B 1.34B 2026-06
Acadia Pharmaceuticals USD 178.32M 11.98M 2026-09
ALKERMES USD 459.09M 2.61M 2026-09
Amgen USD 10.35B 126M 2026-09
Biogen USD 2.38B 15.8M 2026-09
BioMarin Pharmaceutical USD 1.08B 15.31M 2026-09
Bristol-Myers Squibb USD 12.85B 976M 2026-09
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 23.48B 2.3B 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 88M 29.15M 2026-09
J&J USD 19.05B 3.49B 2026-06
Malin Corporation EUR 500K 300K 2024-12
Merck USD 12.56B 354M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 957.3M 70.3M 2026-09
Otsuka Holdings JPY 586.22B 9.17B 2026-09
Ovoca Bio EUR 53K 14K 2025-12
Pfizer USD 17.57B 1.38B 2026-09
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Vertex Pharmaceuticals USD 2.31B 176.7M 2026-09